BlackRock Portfolio holdings
AUM
$5.23T
1-Year Return
24.48%
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
This Quarter Return
-3.54%
1 Year Return
+24.48%
3 Year Return
+103%
5 Year Return
+187.44%
10 Year Return
+430.33%
AUM
$2.93T
AUM Growth
-$181B
(-5.8%)
Cap. Flow
-$23.8B
Cap. Flow
% of AUM
-0.81%
Top 10 Holdings %
Top 10 Hldgs %
19.42%
Holding
5,969
New
125
Increased
2,136
Reduced
2,859
Closed
169
Top Buys
| 1 |
Tesla
TSLA
|
+$1.53B |
| 2 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$778M |
| 3 |
CoStar Group
CSGP
|
+$590M |
| 4 |
Healthcare Realty
HR
|
+$587M |
| 5 |
Rivian
RIVN
|
+$473M |
Top Sells
| 1 |
Apple
AAPL
|
+$1.17B |
| 2 |
CDK
CDK Global, Inc.
CDK
|
+$1.02B |
| 3 |
ACC
American Campus Communities, Inc.
ACC
|
+$1.01B |
| 4 |
Chevron
CVX
|
+$980M |
| 5 |
Johnson & Johnson
JNJ
|
+$900M |
Sector Composition
| 1 | Technology | 22.17% |
| 2 | Healthcare | 15.33% |
| 3 | Financials | 12.53% |
| 4 | Consumer Discretionary | 10.4% |
| 5 | Industrials | 8.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
4451
Corvus Pharmaceuticals
CRVS
$434M
| $411K | ﹤0.01% |
502,942
-2,624
| -0.5% | -$2.14K |
|
4452
Synlogic
SYBX
$18.6M
| $410K | ﹤0.01% |
28,702
-211
| -0.7% | -$3.01K |
|
4453
Quest Resource Holding
QRHC
$34M
| $408K | ﹤0.01% |
48,272
-784
| -2% | -$6.63K |
|
4454
Talphera
TLPH
$19.3M
| $407K | ﹤0.01% |
97,357
+999
| +1% | +$4.18K |
|
4455
Vanguard Russell 1000 Value ETF
VONV
$13.6B
| $407K | ﹤0.01% |
6,825
+6,793
| +21,228% | +$405K |
|
|
LGVN
4456
Longeveron
LGVN
$16.4M
| $406K | ﹤0.01% |
10,973
-27
| -0.2% | -$999 |
|
4457
Pyxis Oncology
PYXS
$113M
| $406K | ﹤0.01% |
206,554
+1,250
| +0.6% | +$2.46K |
|
|
TSPQ
4458
DELISTED
TCW Special Purpose Acquisition Corp.
TSPQ
| $403K | ﹤0.01% |
41,121
+31,121
| +311% | +$305K |
|
4459
Fennec Pharmaceuticals
FENC
$244M
| $399K | ﹤0.01% |
49,367
-2,002
| -4% | -$16.2K |
|
|
REV
4460
DELISTED
Revlon, Inc.
REV
| $399K | ﹤0.01% |
77,153
+57,907
| +301% | +$299K |
|
4461
iShares MSCI Hong Kong ETF
EWH
$737M
| $397K | ﹤0.01% |
21,785
+21,713
| +30,157% | +$396K |
|
|
GTH
4462
DELISTED
Genetron Holdings Limited ADS
GTH
| $397K | ﹤0.01% |
169,238
-5,042
| -3% | -$11.8K |
|
4463
Bank7 Corp
BSVN
$455M
| $393K | ﹤0.01% |
17,721
-2,436
| -12% | -$54K |
|
4464
Candel Therapeutics
CADL
$263M
| $393K | ﹤0.01% |
124,970
-4,407
| -3% | -$13.9K |
|
|
AMRN
4465
Amarin Corp
AMRN
$310M
| $392K | ﹤0.01% |
17,988
+4,393
| +32% | +$95.7K |
|
4466
Corbus Pharmaceuticals
CRBP
$116M
| $389K | ﹤0.01% |
78,661
-242
| -0.3% | -$1.2K |
|
4467
Koss Corp
KOSS
$53.8M
| $389K | ﹤0.01% |
61,264
-756
| -1% | -$4.8K |
|
|
CEA
4468
DELISTED
China Eastern Airlines
CEA
| $389K | ﹤0.01% |
23,526
-1,681
| -7% | -$27.8K |
|
4469
Kingstone Companies
KINS
$195M
| $387K | ﹤0.01% |
145,519
-912
| -0.6% | -$2.43K |
|
4470
iShares Russell Mid-Cap Value ETF
IWS
$14.2B
| $385K | ﹤0.01% |
4,014
-33,731
| -89% | -$3.24M |
|
4471
VanEck Intermediate Muni ETF
ITM
$1.97B
| $383K | ﹤0.01% |
8,791
-27,373
| -76% | -$1.19M |
|
|
LFT
4472
Lument Finance Trust
LFT
$121M
| $383K | ﹤0.01% |
177,402
-24,066
| -12% | -$52K |
|
4473
MainStreet Bancshares
MNSB
$167M
| $381K | ﹤0.01% |
16,710
-3,952
| -19% | -$90.1K |
|
4474
Fathom Holdings
FTHM
$79.4M
| $378K | ﹤0.01% |
71,345
+355
| +0.5% | +$1.88K |
|
|
CYT
4475
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
| $376K | ﹤0.01% |
196,912
-4,592
| -2% | -$8.77K |
|